Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Carvajal Alejandra, Directeur Juridique. Director active across 2 companies, notably Mersana Therapeutics, Inc.. In total, 10 disclosures have been logged. Activity tracked since 26 April 2022. The latest transaction was disclosed on 3 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Alejandra Carvajal is the Chief Legal Officer at Mersana Therapeutics, Inc. She is responsible for managing the company's legal affairs and compliance. Her role is essential for protecting the company's interests and ensuring adherence to regulations.